165 related articles for article (PubMed ID: 17893691)
1. Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels.
Halperin F; Anderson RJ; Mulder JE
Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):721-5. PubMed ID: 17893691
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia: lessons learned.
Lewiecki EM; Urig EJ; Williams RC
Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
[TBL] [Abstract][Full Text] [Related]
3. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.
Hernandez JD; Wesseling K; Boechat MI; Gales B; Salusky IB
Nat Clin Pract Nephrol; 2007 Apr; 3(4):227-32. PubMed ID: 17389892
[TBL] [Abstract][Full Text] [Related]
4. Bone densitometry in a patient with hypophosphatemic osteomalacia.
Negri AL; Bogado CE; Zanchetta JR
J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
[TBL] [Abstract][Full Text] [Related]
5. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
7. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
8. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
10. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
Drezner MK; Feinglos MN
J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
12. [Osteomalacia cured by resection of cutaneous neurinoma].
Caille A; Crouzet J; Mimoune H; Duterque M; Perrin P; Verola O
Ann Dermatol Venereol; 1996; 123(12):829-31. PubMed ID: 9636774
[TBL] [Abstract][Full Text] [Related]
13. Osteomalacia in Crohn's disease.
Dedeoglu M; Garip Y; Bodur H
Arch Osteoporos; 2014; 9():177. PubMed ID: 24847674
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced osteomalacia: a case of diagnostic dilemma.
Robertson A; Mansberg R; Mansberg V; Van der Wall H; Hooper M
Clin Nucl Med; 2007 Aug; 32(8):631-4. PubMed ID: 17667438
[TBL] [Abstract][Full Text] [Related]
16. [Oncogenic osteomalacic myopathy; a case report].
Urushitani M; Nishinaka K; Udaka F; Kameyama M
Rinsho Shinkeigaku; 1995 Feb; 35(2):195-200. PubMed ID: 7781239
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.
Fuentealba C; Pinto D; Ballesteros F; Pacheco D; Boettiger O; Soto N; Fernandez W; Gabler F; Gonzales G; Reginato AJ
J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry.
Siris ES; Clemens TL; Dempster DW; Shane E; Segre GV; Lindsay R; Bilezikian JP
Am J Med; 1987 Feb; 82(2):307-12. PubMed ID: 3812526
[TBL] [Abstract][Full Text] [Related]
19. A man with osteoblastic metastasis and hypocalcaemia.
Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
